Burnham & Co’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28.5K Hold
200
– – 0.02% 144
2026
Q2
$31.3K Hold
200
– – 0.03% 138
2026
Q1
$30.6K Buy
+200
New +$30.7K 0.03% 126

Other funds holding NVS

Burnham & Co's NVS Position: Q3 2026 in Review

Burnham & Co held its Novartis (NVS) position steady in Q3 2026 at 200 shares worth $28.5K. The position accounts for 0.02% of the portfolio, ranked #144.

Burnham & Co first reported a position in NVS in Q1 2026 and has held it in 3 quarters since. The position peaked at $31.3K in Q2 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Burnham & Co held 200 shares of Novartis worth $28.5K as of Q3 2026.
  • Burnham & Co left its Novartis share count unchanged in Q3 2026.
  • Novartis made up 0.02% of Burnham & Co's portfolio in Q3 2026, its #144 holding.
  • Burnham & Co first reported a position in Novartis in Q1 2026 and has held it in 3 quarters since.
  • Burnham & Co's Novartis position peaked at $31.3K in Q2 2026.
  • 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Burnham & Co's 13F filing for Q3 2026, filed 12 Nov 2026.